BSEM (BioStem Technologies) Inventory Turnover: 0.53 (As of Sep. 2025)

What is BioStem Technologies Inventory Turnover?

BioStem Technologies BSEM +0.62% 49 Inventory Turnover is 0.53 as of Sep. 2025. GuruFocus rates BSEM with a GF Score™ of 49/100 and a GF Value™ of $141.58 (Possible Value Trap). The stock has 3 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. BioStem Technologies's Cost of Goods Sold for the three months ended in Sep. 2025 was $1.2 Mil. BioStem Technologies's Average Total Inventories for the quarter that ended in Sep. 2025 was $2.3 Mil. BioStem Technologies's Inventory Turnover for the quarter that ended in Sep. 2025 was 0.53.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioStem Technologies's Days Inventory for the three months ended in Sep. 2025 was 172.53.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioStem Technologies's Inventory-to-Revenue for the quarter that ended in Sep. 2025 was 0.22.

BioStem Technologies (OTCPK:BSEM) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioStem Technologies's Days Inventory for the three months ended in Sep. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2025 )	/	Cost of Goods Sold (Q: Sep. 2025 )	*	Days in Period
	=	2.2765	/	1.204	*	365 / 4
	=	172.53

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioStem Technologies's Inventory to Revenue for the quarter that ended in Sep. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2025 )	/	Revenue (Q: Sep. 2025 )
	=	2.2765	/	10.473
	=	0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

BioStem Technologies Inventory Turnover Related Terms

BioStem Technologies Inventory Turnover Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Inventory Turnover can be seen below:

BioStem Technologies Inventory Turnover Chart

BioStem Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventory Turnover

Get a 7-Day Free Trial

1.99

3.52

2.69

2.39

11.07

BioStem Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Sep21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23	Dec23	Sep24	Dec24	Sep25
Inventory Turnover	Get a 7-Day Free Trial															0.71	1.09	3.10	1.81	0.53

49GF Score

BioStem Technologies Inc BSEM

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BioStem Technologies Inventory Turnover Calculation

BioStem Technologies's Inventory Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Inventory Turnover (A: Dec. 2024 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2024 )	/ (	(Total Inventories (A: Dec. 2023 )	+	Total Inventories (A: Dec. 2024 ))	/	count )
=	13.746	/ (	(0.659	+	1.824)	/	2 )
=	13.746	/	1.2415
=	11.07

BioStem Technologies's Inventory Turnover for the quarter that ended in Sep. 2025 is calculated as

	Inventory Turnover (Q: Sep. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Sep. 2025 )	/ (	(Total Inventories (Q: Dec. 2024 )	+	Total Inventories (Q: Sep. 2025 ))	/	count )
=	1.204	/ (	(1.824	+	2.729)	/	2 )
=	1.204	/	2.2765
=	0.53

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.53 mean?

BioStem Technologies (BSEM) has a Inventory Turnover of 0.53 as of Sep. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on BioStem Technologies and its competitors.

Is BioStem Technologies' Inventory Turnover too high?

BioStem Technologies' current Inventory Turnover is 0.53. Overall, BioStem Technologies has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does BioStem Technologies' Inventory Turnover compare to XLO and TCRX?

BioStem Technologies' Inventory Turnover of 0.53 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on BioStem Technologies and its competitors. BioStem Technologies's current Inventory Turnover is 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioStem Technologies stock overvalued right now?

Based on GuruFocus' analysis, BioStem Technologies (BSEM) is currently considered Possible Value Trap. The stock's GF Value™ is $141.58, compared to a current price of $3.24 — trading 97.7% below its estimated fair value. The current Inventory Turnover is 0.53. BioStem Technologies' overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Inventory Turnover is 0.53 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioStem Technologies (BSEM) Overvalued in 2026?

Based on GuruFocus' analysis, BioStem Technologies stock appears to be undervalued. The current stock price of $3.24 is trading 97.7% below its estimated GF Value™ of $141.58. GuruFocus considers BioStem Technologies to be Possible Value Trap.

Key valuation signals for BSEM:

Inventory Turnover: 0.53
GF Value™: $141.58 vs. price of $3.24 (97.7% below fair value)
GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the BSEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioStem Technologies Business Description

Industry Healthcare Biotechnology

Comparable Companies XLO TCRX MNOV PMVP FLNA BOLD INKT DWTX CING IMA VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

49GF Score

Get the complete analysis for BSEM

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.24

Price

$141.58

GF Value

View BSEM Analysis

See Inventory Turnover data for all stocks →